Avanced Non Small Cell Lung Cancer clinical trials

Explore recruiting avanced non small cell lung cancer clinical trials.

Also recruiting in Europe

Avanced Non Small Cell Lung Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

First in human study of BAY2927088 in participants who have advanced non-small cell lung cancer (NSCLC) with mutations in the genes of epidermal growth factor receptor (EGFR) and/or human epidermal growth factor receptor 2 (HER2)

Netherlands, Spain, Belgium, Italy, Portugal, France +1 more

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Avanced Non Small Cell Lung Cancer trials by city

Avanced Non Small Cell Lung Cancer in Toronto Avanced Non Small Cell Lung Cancer in Vancouver Avanced Non Small Cell Lung Cancer in Montreal Avanced Non Small Cell Lung Cancer in Calgary Avanced Non Small Cell Lung Cancer in Edmonton Avanced Non Small Cell Lung Cancer in Ottawa Avanced Non Small Cell Lung Cancer in Winnipeg Avanced Non Small Cell Lung Cancer in Quebec City Avanced Non Small Cell Lung Cancer in Hamilton Avanced Non Small Cell Lung Cancer in Kitchener Avanced Non Small Cell Lung Cancer in London Avanced Non Small Cell Lung Cancer in Halifax Avanced Non Small Cell Lung Cancer in New York Avanced Non Small Cell Lung Cancer in Los Angeles Avanced Non Small Cell Lung Cancer in Chicago Avanced Non Small Cell Lung Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease